The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Predicting renal outcome in IgA nephropathy.
Radford, M. G., Donadio, J. V., Bergstralh, E. J., & Grande, J. P. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v82199 · Cited by 440
Natural history and risk factors for immunoglobulin a nephropathy in Japan
Koyama, A., Igarashi, M., & Kobayashi, M. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90333-4 · Cited by 326
Yoshida, H., Mitarai, T., Kawamura, T., Kitajima, T., Miyazaki, Y., Nagasawa, R., Kawaguchi, Y., Kubo, H., Ichikawa, I., & Sakai, O. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118270 · Cited by 322
Alamartine, E., Sabatier, J.-C., Guerin, C., Berliet, J.-M., & Berthoux, F. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80284-8 · Cited by 283
Ibels, L. S., & Györy, A. Z. (1994) · Medicine · doi:10.1097/00005792-199403000-00002 · Cited by 244
Polymorphisms in Angiotensin-Converting-Enzyme Gene and Progression of Iga Nephropathy
Harden, P. N., Rowe, P. A., Rodger, R. S. C., Junor, B. J. R., Briggs, J. D., Jardine, A. G., Geddes, C., Boulton-Jones, M., Mcllroy, J. H., Connell, J. M. C., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91088-3 · Cited by 215
Hunley, T. E., Julian, B. A., Phillips, J. A., Summar, M. L., Yoshida, H., Horn, R. G., Brown, N. J., Fogo, A., Ichikawa, I., & Kon, V. (1996) · Kidney International · doi:10.1038/ki.1996.81 · Cited by 191
IgA nephropathy: Long-term prognosis for pediatric patients
Wyatt, R. J., Kritchevsky, S. B., Woodford, S. Y., Miller, P. M., Roy, S., Holland, N. H., Jackson, E., & Bishof, N. A. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70027-7 · Cited by 138
Johnston, P. A., BROWN, J., Braumholtz, D. A., & DAVISION, A. (1992) · QJM · doi:10.1093/oxfordjournals.qjmed.a068700 · Cited by 131
Hogg, R. J., Silva, F. G., Wyatt, R. J., Reisch, J., Argyle, J. C., & Savino, D. A. (1994) · Pediatric Nephrology · doi:10.1007/bf00868251 · Cited by 121
Cited by
Remission of Proteinuria Improves Prognosis in IgA Nephropathy
Reich, H. N., Troyanov, S. A. A., Scholey, J. W., & Cattran, D. C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050526 · Cited by 639
Interleukin-18 in Health and Disease
Yasuda, K., Nakanishi, K., & Tsutsui, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030649 · Cited by 563
Rodrigues, J. C., Haas, M., & Reich, H. N. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07420716 · Cited by 555
Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome
D’Amico, G. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.01.001 · Cited by 500
Self-citationCoppo, R., on behalf of the VALIGA study of the ERA-EDTA Immunonephrology Working Group, Troyanov, S., Bellur, S., Cattran, D., Cook, H. T., Feehally, J., Roberts, I. S. D., Morando, L., Camilla, R., et al. (2014) · Kidney International · doi:10.1038/ki.2014.63 · Cited by 498
Corticosteroid Effectiveness in IgA Nephropathy: Long-Term Results of a Randomized, Controlled Trial
Pozzi, C., Andrulli, S., Del Vecchio, L., Melis, P., Fogazzi, G. B., Altieri, P., Ponticelli, C., & Locatelli, F. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000103869.08096.4f · Cited by 484
Suzuki, H., Fan, R., Zhang, Z., Brown, R., Hall, S., Julian, B. A., Chatham, W. W., Suzuki, Y., Wyatt, R. J., Moldoveanu, Z., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38468 · Cited by 450
The Tn Antigen—Structural Simplicity and Biological Complexity
Ju, T., Otto, V. I., & Cummings, R. D. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201002313 · Cited by 363
Predicting the Risk for Dialysis or Death in IgA Nephropathy
Berthoux, F., Mohey, H., Laurent, B., Mariat, C., Afiani, A., & Thibaudin, L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040355 · Cited by 361
Treatment of IgA Nephropathy with ACE Inhibitors: A Randomized and Controlled Trial
Praga, M., Gutiérrez, E., González, E., Morales, E., & Hernández, E. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068460.37369.dc · Cited by 345
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy
Magistroni, R., D’Agati, V. D., Appel, G. B., & Kiryluk, K. (2015) · Kidney International · doi:10.1038/ki.2015.252 · Cited by 302
Lafayette, R. A., Canetta, P. A., Rovin, B. H., Appel, G. B., Novak, J., Nath, K. A., Sethi, S., Tumlin, J. A., Mehta, K., Hogan, M., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060640 · Cited by 300
Tøndel, C., Vikse, B. E., Bostad, L., & Svarstad, E. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02150212 · Cited by 268
Goto, M., Wakai, K., Kawamura, T., Ando, M., Endoh, M., & Tomino, Y. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp273 · Cited by 255
Corticosteroid therapy in IgA nephropathy
Lv, J., Xu, D., Perkovic, V., Ma, X., Johnson, D. W., Woodward, M., Levin, A., Zhang, H., & Wang, H. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111112 · Cited by 190
Expression of MicroRNAs in the Urinary Sediment of Patients with IgA Nephropathy
Wang, G., Kwan, B. C.-H., Lai, F. M.-M., Chow, K.-M., Kam-Tao Li, P., & Szeto, C.-C. (2010) · Disease Markers · doi:10.1155/2010/396328 · Cited by 85
Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy
Duan, Z.-Y., Cai, G.-Y., Bu, R., Lu, Y., Hou, K., & Chen, X.-M. (2016) · Scientific Reports · doi:10.1038/srep23498 · Cited by 61
Metadata
- Authors
- D’Amico, G.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 36
- Issue
- 2
- Pages
- 227-237
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2139030893
- Cited by
- 499
- References
- 20
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.